AMBROSIA BIO
Ambrosia Bio develops an enzyme technology platform that converts obesity-promoting sugars into minimal-calorie rare sugars.
AMBROSIA BIO
Social Links:
Industry:
Biotechnology Food Processing Nutrition
Founded:
2020-01-01
Address:
Yavne, HaMerkaz, Israel
Country:
Israel
Website Url:
http://www.ambrosia.bio
Total Employee:
1+
Status:
Active
Contact:
+972-544202857
Email Addresses:
[email protected]
Total Funding:
130 K USD
Technology used in webpage:
U.S. Server Location
Similar Organizations
Chimeron Bio
Chimeron Bio develops agents for personalized cancer gene therapy.
Clario
Clario delivers the endpoint technology solutions for clinical trials.
Gavan
Gavan produces natural proteins designed to improve the quality of food using natural resources.
Longevity Biotech
Longevity Biotech develops a new class of therapeutics via artificial protein technology that focuses on pharmaceutical preparation.
Prolocor
Prolocor is a biotechnology company that develops diagnostic tests for cardiovascular diseases.
Rx Green Technologies
Rx Green Technologies delivers and supports research-backed products to commercial cannabis cultivators.
Current Employees Featured
Founder
Investors List
Official Site Inspections
http://www.ambrosia.bio Semrush global rank: 8.05 M Semrush visits lastest month: 658
- Host name: 147.62.236.23.bc.googleusercontent.com
- IP address: 23.236.62.147
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
More informations about "Ambrosia Bio"
Ambrosia Bio - Funding, Financials, Valuation & Investors
Ambrosia Bio develops an enzyme technology platform that converts obesity-promoting sugars into minimal-calorie rare sugars.See details»
Ambrosia Bio - LinkedIn
Ambrosia Bio | 844 followers on LinkedIn. We are forging a healthier world, one rare sugar at a time. | AMBROSIA BIO has developed a disruptive, evolutionary enzyme technology platform that is ...See details»
Ambrosia Bio 2025 Company Profile: Valuation, Funding
Information on valuation, funding, cap tables, investors, and executives for Ambrosia Bio. Use the PitchBook Platform to explore the full profile.See details»
Rare sugars | Allulose | Ambrosia Bio LTD
AMBROSIA BIO harnesses synthetic biology to overcome Obesity. By providing the food and beverages industry across the globe the opportunity to diversify their offering by transforming …See details»
Ambrosia Biosciences — Boulder Ventures Ltd.
Business: Ambrosia Biosciences is a pharmaceutical company developing a best-in-class orally available, small molecule drug targeting GLP-1 and incretin biology, that is safe, effective, …See details»
Ambrosia Bio - Israeli Startup | Startup Nation Finder
Jun 27, 2022 Ambrosia Bio has developed a disruptive enzyme technology platform that is used to design superior enzymes capable of converting obesity-promoting industrial sugars into …See details»
AMBROSIA BIO - BRINC
AmbrosiaBio is a biotech venture that develops an enzyme-based technology that converts fruit (or vegetable) sugar reservoirs to various low- to no-calorie rare sugars (e.g. allulose) in a cost …See details»
AMBROSIA BIO - VentureRadar
"AMBROSIA’s proprietary, disruptive enzyme technology platform is designed to convert high-calorie, obesity-promoting sugars into both rare, practically no-calorie sugars, such as Allulose …See details»
Ambrosia Bio - Products, Competitors, Financials, Employees ...
About Ambrosia Bio Ambrosia Bio specializes in the development of rare sugars as sugar replacements, focusing on the health and food industries. The company offers allulose, a …See details»
Ambrosia Bio: enabling cost effective sugar alternatives
Jan 13, 2025 This is where Ambrosia Bio comes in - they enable the cost-effective replacement of sugar. Commercialisation of their technology could have a significant long-term impact in reducing obesity, while allowing consumers to …See details»
Ambrosia Biosciences - Crunchbase Company Profile & Funding
Ambrosia Biosciences offers drug development services for small molecule-based therapies for obesity and other metabolic disorders.See details»
Ambrosia Biosciences 2025 Company Profile: Valuation, Funding ...
Information on valuation, funding, cap tables, investors, and executives for Ambrosia Biosciences. Use the PitchBook Platform to explore the full profile.See details»
Sugar is the new tobacco - Ambrosia.bio
‘No sugar added’ is often a misleading label. Freshly squeezed orange juice, for instance, contains the same amount of sugar as sweetened sodas. This bitter truth applies to every …See details»
Ambrosia Biosciences - 2025 Company Profile - Tracxn
Mar 23, 2025 Ambrosia Biosciences is a series A company based in Boulder (United States), founded in 2024 by Nick Traggis. It operates as a Developer of small molecule-based …See details»
Ambrosia Bio ltd - F6S
Ambrosia Bio ltd - Both consumers and regulatory authorities across the globe are pressing for the reduction of high-calorie sugar load in food and beverage products. Reducing sugar levels …See details»
Ambrosia Bio Leverages Ginkgo Enzyme Services to Develop a …
Jun 29, 2023 Ambrosia aims to make the production of allulose, a next-generation sugar replacement, more scalable and affordable JERUSALEM and BOSTON, June 29, 2023 …See details»
Ambrosia Bio | StartupHub.ai
Jan 20, 2020 Description: AMBROSIA BIO has developed a disruptive, evolutionary enzyme technology platform that is used to design superior enzymes to convert obesity-promoting …See details»
Ambrosia Bio - Updates, News, Events, Signals & Triggers
Ambrosia Bio develops an enzyme technology platform that converts obesity-promoting sugars into minimal-calorie rare sugars.See details»
Ambrosia Bio - GreyB
Solution Effectiveness Ambrosia Bio’s rare sugars, such as Allulose, are considered ideal sugar replacements because they have a similar taste profile and sweetness to sugar but don’t have …See details»